COMPOSITIONS, METHODS AND SYSTEMS FOR SYNTHESIS AND USE OF IMAGING AGENTS Russian patent published in 2020 - IPC C07C309/66 C07C309/73 C07C303/28 C07C303/30 C07C277/08 C07C279/08 A61K49/10 A61K51/04 

Abstract RU 2710736 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention generally relates to a pharmaceutically acceptable salt of the compound of formula (IV), wherein the salt contains a halide, phosphate, sulphate, trifluoroacetate, toluenesulphonate, acetate, mesylate (methanesulphonic) or benzoate anion; R1 is phenyl which is optionally substituted with halogen or C1-6 alkyl; R3, R4, R5 and R6 can be identical or different and separately represent hydrogen or halogen; m is equal to 3; n equals 1. Pharmaceutically acceptable salt of the compound of formula (IV) is obtained by reacting a compound of formula (II), where each of R2, identical or different, is hydrogen or tert-butoxycarbonyl, provided that at least one of R2 is tert-butoxycarbonyl with an acid to form a pharmaceutically acceptable salt of the compound of formula (IV). Invention also relates to a method of producing a pharmaceutically acceptable salt of a compound of formula (V) comprising reacting a pharmaceutically acceptable salt of the compound of formula (IV) with a fluoride source in the presence of ammonium, carbonate or bicarbonate salt to form a pharmaceutically acceptable salt of the compound of formula (V). Invention relates to salt of formula (VI) and (VII), where X is formate or ascorbate, respectively.

EFFECT: compounds of formula (VI) and (VII) are intended for preparing a pharmaceutical composition for visualizing heart failure in a subject.

47 cl, 7 tbl, 10 dwg, 32 ex

Similar patents RU2710736C2

Title Year Author Number
METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF 2011
  • Cesati Richard R.
  • Cheesman Edward H.
  • Lazewatsky Joel
  • Radeke Heike S.
  • Castner James F.
  • Mongeau Enrico
  • Zdankiewicz Dianne D.
  • Siegjer Robert Wilburn
  • Devine Marybeth
RU2631500C2
CONTRAST AGENT FOR MYOCARDIAL PERFUSION VISUALIZATION 2012
  • Johansson Martin
RU2629840C2
EFFICIENT SYNTHESIS OF ETHYLENEDICYSTEINE-SUGAR CONJUGATES FOR IMAGING AND THERAPY 2013
  • Yang Devid Dzh.
  • Yuj Dun-Fan
RU2674673C2
THERAPEUTIC COMPOUNDS AND COMPOSITIONS 2019
  • Hayward, Neil J.
  • Chenard, Bertrand L.
  • Xu, Yuelian
  • Dorow, Roberta L.
  • Matison, Michael E.
  • Kolchinski, Alexander
  • Fornicola, Richard
RU2813780C2
11,13-MODIFIED SAXITOXINS FOR PAIN TREATMENT 2018
  • Mulkakhi, Dzhon
  • Padzhoukhesh, Khassan
  • Milanich, Dzhordzh
  • Delvig, Anton
  • Bekli, Dzhejkob
  • Shibuja, Grant Masaaki
  • Dyu Bua, Dzhastin
RU2778455C2
ORAL CARE COMPOSITIONS 2013
  • Santarpia Ralph Peter Iii
  • Sullivan Richard J.
  • Petrou Irene
  • Josias Wilbens
  • Robinson Richard S.
RU2683030C1
PSMA-BINDING AGENTS AND USING THEM 2009
  • Pomper Martin Gilbert
  • Mis Ronni Charl'Z
  • Chen In
RU2494096C2
DERIVATIVES OF TRICYCLIC INDOLE AS PBR LIGANDS 2011
  • Achanath Randha
  • Balaji Srinath
  • Fairway Steven Michael
  • Mantzilas Dimitrios
  • Mokkapati Umamaheshwar
  • O'Shea Dennis
  • Passmore Joanna Marie
  • Shan Bo
  • Trigg William John
  • Wadsworth Harry John
  • Kadavilpparampu Mohamed Afsal Mohammed
RU2551423C2
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS 2009
  • Patterson Lori Dzhin
  • Stehndzhlehnd Ehrik L.
  • Tsipfel' Shejla
  • Long Dehniel D.
RU2515612C2
IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS 2020
  • Ahmad, Omar
  • Fensome, Andrew
  • Fisher, Ethan Lawrence
  • Lachapelle, Erik Alphie
  • Unwalla, Rayomand J
  • Xiao, Jun
  • Zhang, Lei
RU2785124C1

RU 2 710 736 C2

Authors

Purokhit Adzhaj

Benites Pedro

Chizman Edvard Kh.

Lazevatski Dzhoel

Li Veronika

Chezati Richard R. Iii

Lubi Richard

Radeke Khajke S.

Dates

2020-01-10Published

2011-05-11Filed